Treatment of the SpA-like disease in HLA B27 transgenic animals

Clin Exp Rheumatol. 2002 Nov-Dec;20(6 Suppl 28):S50-1.

Abstract

A major involvement of the immune system and of microbial flora in the HLA-B27 transgenic rat model of spondylarthropathy was demonstrated. The role of inflammatory pathways, such as cytokines and inducible nitric oxide synthase (iNOS) was investigated. Treatment with IL-10 failed to improve established disease, whereas such improvement was achieved with IL-11. In contrast, aggravation was observed after treatment with selective inhibitor of iNOS.

MeSH terms

  • Animals
  • Animals, Genetically Modified / genetics
  • Bacteria, Anaerobic / physiology
  • HLA-B27 Antigen / genetics*
  • Immune System / physiopathology
  • Inflammation Mediators / metabolism
  • Interleukin-11 / therapeutic use
  • Rats
  • Spondylarthropathies / drug therapy
  • Spondylarthropathies / microbiology
  • Spondylarthropathies / physiopathology*

Substances

  • HLA-B27 Antigen
  • Inflammation Mediators
  • Interleukin-11